| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/18/2004 | CN1520814A Ginkgo leaf extract and its preparation |
| 08/18/2004 | CN1520813A Prion exosomatic inhibition agent |
| 08/18/2004 | CN1520812A Troxerutin injection and its preparation method |
| 08/18/2004 | CN1520811A External use composition containing oil-soluble licorice extract and its stabilization method |
| 08/18/2004 | CN1520810A Fatty liver therapeutic drug |
| 08/18/2004 | CN1520809A Acidum transamicum sodium chloride injection liquid preparation method |
| 08/18/2004 | CN1520808A Carmustine precursor liposome powder injection formulation and process for preparing |
| 08/18/2004 | CN1520807A Wound disinfection cleaning agent and method for making same |
| 08/18/2004 | CN1520806A Novel use of agmatine |
| 08/18/2004 | CN1520805A Ubiquinone containing composition |
| 08/18/2004 | CN1162445C Jackfruit cycloalkane triterpenic saponin compound and its application in the treatment of cardiovascular disease |
| 08/18/2004 | CN1162443C Cellular injury response element and uses thereof |
| 08/18/2004 | CN1162442C Novel erythromycin derivatives, method of preparation and application as medicines |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162432C 2,3-benzodiazepine derivatives |
| 08/18/2004 | CN1162430C High-tension condensed ring nicotine analogue, preparation process and use thereof |
| 08/18/2004 | CN1162429C Tricyclic vasopressin agonists |
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/18/2004 | CN1162424C Quinoline-4-yl derivative II |
| 08/18/2004 | CN1162414C Benzothiadiazine derivs., preparation method and pharmaceutical compositions contg. same |
| 08/18/2004 | CN1162408C Process for preparing oxazolines from tetrahydrofurans |
| 08/18/2004 | CN1162179C Medicament for curing rhinitis |
| 08/18/2004 | CN1162170C Leukoderma treating medicine and its preparation |
| 08/18/2004 | CN1162159C Compound heparin aqueogel and its preparing process |
| 08/18/2004 | CN1162158C Slow realease breviscapine formulation having function of promoting blood circulation and removing blood stasis |
| 08/18/2004 | CN1162157C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 08/18/2004 | CN1162156C Use of olanzapine and fluoxetine in preparing medicine for psychosis |
| 08/18/2004 | CN1162155C Application of phenazinone derivative in preparing antineoplastic and tumor transfer-resistant medicines |
| 08/18/2004 | CN1162154C Lauryl piperazine, lauryl diethanolamine and the application of their derivatives in extracorporeal marrow purification |
| 08/18/2004 | CN1162153C Benzothiophenes series, formulations containing same, and methods |
| 08/18/2004 | CN1162152C Remedies for diabetes |
| 08/18/2004 | CN1162151C Patassium channel activators |
| 08/18/2004 | CN1162150C Theopolyphenol composition for injection and its preparing process |
| 08/18/2004 | CN1162149C Medicinal compositions for preventing or treating viral myocarditis |
| 08/18/2004 | CN1162141C Formulations for reducing skin irritation and use |
| 08/18/2004 | CN1162096C Potassium calcium citrate compositions and methods for production |
| 08/17/2004 | USRE38566 Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome |
| 08/17/2004 | US6778854 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 08/17/2004 | US6777578 Inhibitor of tubulin polymerization; antineoplastic activity |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777564 Anthraquinone compound |
| 08/17/2004 | US6777560 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777550 N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors |
| 08/17/2004 | US6777543 13-methyl erythromycin derivatives |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777448 Rafoxanide, for the treatment of parasitic diseases in farm and domestic animals, like the liver fluke or bot fly infestations |
| 08/17/2004 | US6777445 Fullerene pharmaceutical compositions for preventing or treating disorders |
| 08/17/2004 | US6777444 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 08/17/2004 | US6777441 For therapy and prophylaxis |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/17/2004 | US6777438 Inhibitors of farnesyl protein transferase |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777436 Synergistic mixture of angiotensin inhibitors, boric acid, ethylenediaminetetraacetic acid and active drug |
| 08/17/2004 | US6777434 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/17/2004 | US6777430 Phenylsulphonyl derivatives as 5-HT receptor ligands |
| 08/17/2004 | US6777429 Ophthalmic composition |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777426 Imidazole and imidazoline derivatives and uses thereof |
| 08/17/2004 | US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering |
| 08/17/2004 | US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 08/17/2004 | US6777422 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 08/17/2004 | US6777421 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound |
| 08/17/2004 | US6777419 Pyrazolo [4,3-d]pyrimidines |
| 08/17/2004 | US6777418 For treating or preventing emphysema, cancer and dermatological disorders |
| 08/17/2004 | US6777417 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors |
| 08/17/2004 | US6777416 Isoxazolo pyrimidinones and the use thereof |
| 08/17/2004 | US6777415 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777407 7bh-cyclopenta(b)(1,4)diazepino(6, 7, 1-hi)indole or a salt, useful for treatment of schizophrenia, obsessive compulsive disorder, depression, anxiety, panic disorder, obesity or epilepsy |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/17/2004 | US6777404 Use of corticotropin releasing factor antagonists and related compositions |
| 08/17/2004 | US6777401 Solution comprising: a) water; b) propylene glycol; c) 2-propanol; and d) hydrocortisone; dispensing solution into an external ear canal and contacting a wick with the solution to expand the wick within the canal |
| 08/17/2004 | US6777400 Anti-inflammatory androstane derivative compositions |
| 08/17/2004 | US6777399 Anti-inflammatory androstane derivative compositions |
| 08/17/2004 | US6777398 Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products |
| 08/17/2004 | US6777397 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777394 Methods and compositions for regulating imidazoline receptors |
| 08/17/2004 | US6777393 Bacterial and protozoa infections in mammals, fish and birds |
| 08/17/2004 | US6777389 Inhibiting cutaneous effects of aging |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6777217 Genes which are involved in the control of chromatin structure and, thus in transcription and translation; used to control cell proliferation and differentiation in vitro and in vivo |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6777200 Kinesin motor modulators derived from the marine sponge Adocia |
| 08/17/2004 | US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 08/17/2004 | US6777005 Catechin, epicatechin, and procyanidin oligomer extracts |
| 08/17/2004 | US6777004 Oleanane triterpenoid oligoglycoside; food preservative |
| 08/17/2004 | US6776982 Autoclavable pharmaceutical compositions containing a chelating agent |
| 08/17/2004 | US6776979 Periodontal treatment compound and method of use |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | US6776164 Enhanced intravaginal devices |
| 08/17/2004 | CA2334257C Treatment of osteoporosis with ep2/ep4 receptor selective agonists |
| 08/17/2004 | CA2325371C Method of increasing bone toughness and stiffness and reducing fractures |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |